Select Page

TCAR Surveillance Project Study Results

September 15, 2020
TransCarotid Revascularization with Dynamic Flow reversal versus Carotid Endarterectomy in the Vascular Quality Initiative Surveillance Project

Malas, Mahmoud B. MD, MHS; et al.

October 7, 2020

Effects of Timing on In-hospital and One-year Outcomes after TransCarotid Artery Revascularization

Christina L. Cui, BS; et al.

December 17, 2019

Association of Transcarotid Artery Revascularization vs Transfemoral Carotid Artery Stenting With Stroke or Death Among Patients With Carotid Artery Stenosis

Marc L. Schermerhorn; et al.

January 1, 2020

Learning Curve for Surgeons Adopting Transcarotid Artery Revascularization Based on the Vascular Quality Initiative – Transcarotid Artery Revascularization Surveillance Project

Vikram S. Kashyap; et al.

June 18, 2019
In-hospital Outcomes of Transcarotid Arter Revascularization and Carotid Endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative

Marc L. Schermerhorn; et al.

June 6, 2018

Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative

Mahmoud B. Malas; et al.

ROADSTER 2 Study Results

August 19, 2020
Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease

Vikram S. Kashyap; et al.

ROADSTER IDE Study Results

November, 2015
Results of the ROADSTER Multicenter Trial of Transcarotid Stenting with Dynamic Flow Reversal.

Kwolek CJ; et al.

January, 2017
One-Year Results of the ROADSTER Multicenter Trial of Transcarotid Stenting With Dynamic Flow Reversal

Mahmoud Malas; et al.

August, 2017
Pre- and Post-Transcarotid Artery Revascularization Characteristics of Common Carotid Artery: A Post Hoc Analysis of ROADSTER-1 Trial

Raghu L. Motaganahalli; et al.

September, 2016
The ROADSTER Investigational Device Exemption Trial Leads to Food and Drug Administration Approval of the First Stent Labeled for Trans-Carotid Artery Revascularization

Manish Mehta; et al.

TCAR Procedure Publications

January, 2020
Opioid Consumption after Carotid Revascularization

Mark D. Balceniuk; et al.

November 15, 2019
Endovascular Stenting of Supra-Aortic Lesions Using a Transcarotid Retrograde Approach and Flow Reversal: A Multicenter Case Series

Mark D. Balceniuk; et al.

July, 2019
A Multi-institutional Analysis of Transcarotid Artery Revascularization Compared to Carotid Endarterectomy

Vikram S. Kashyap; et al.

May, 2019
Patient selection for transcarotid artery (stent) revascularization/span>

Richard P Cambria

May, 2019
Anatomic Eligibility for Transcarotid Artery Revascularization and Transfemoral Carotid Artery Stenting

Winona W. Wu; et al.

December, 2018
Temporary Reversal of Blood Flow During Transcarotid Artery Revascularization Does Not Change Brain Electrical Activity in Lead-In Cases of the ROADSTER 1 Multicenter Trial

Alexander H. King; et al.

June, 2018
Postapproval Safety and Efficacy of Transcarotid Arterial Revascularization

Mark D. Balceniuk; et al.

June, 2018
The Learning Curve of Transcarotid Artery Revascularization/span>

Alexander H. King; et al.

April, 2017
Transcarotid Artery Revascularization With Flow Reversal*

Alpaslan A; et al.

March, 2017
Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system

Malas MB; et al.

June, 2016
Transcarotid Artery Revascularization With High-Rate Flow Reversal Embolic Protection Demonstrates Improved Stroke and Death Rate Following FDA Premarket Clearance

Christopher J. Kwolek; et al.

June, 2016
1-Year Follow-up After Transcarotid Artery Revascularization (TCAR) With Enroute Transcarotid Neuroprotection System

Ignacio Leal; et al.

April, 2016
Transcervical Carotid Stenting With Dynamic Flow Reversal Demonstrates Embolization Rates Comparable to Carotid Endarterectomy*

Plessers M; et al.

December, 2015
New technologies for CAS that might overcome the burden of microembolization.

Yamada R; et al.

December, 2011
First clinical use of a novel neurovascular access and neuroprotection system demonstrates complete absence of emboli by transcranial Doppler during carotid artery stenting.

Pinter L; et al.

* The ENROUTE NPS and Stent Systems are approved for use in the EU in patients at standard risk for complications from CEA. These indications have not been evaluated by the US FDA.
The links on this page take you away from the Silk Road Medical website. These websites are not operated by Silk Road Medical. Silk Road Medical does not control the content of these websites.